Product name | Olmesartan Medoxomil |
CAS No. | 144689-63-4/ 144689-78-1 |
Molecular Formula | C30H32N6O6 |
Molecular Weight | 572.612 |
Quality Standard | 98% up by HPLC |
Appearance | White powder |
COA of Olmesartan Medoxomil |
Test Items | Specifications | Results |
Appearance | White or almost white crystalline powder | white crystalline powder |
Identification IR HPLC |
Must conform to reference standard Must conform to reference standard |
Conforms Conforms |
Water | Not more than 2.0% | 1.6% |
Residue On Ignition | Not more than 0.3% | 0.15% |
Heavy Metals | Not more than 20ppm | complies |
Related Impurities | Individual impurity NMT1.0% | 0.32% |
Total Impurities | Not more than 2.0% | 0.74% |
Assay | ≥ 98.0% | 98.9% |
Conclusion: It complies with all the requirements of In-house standard .
|
Function of Olmesartan
Olmesartan has better efficacy than the sartan drugs that were marketed earlier, such as Losartan. Olmesartan is an ideal anti-hypertensive drug that has good effects on all types of hypertension. Its outstanding feature is that it has a long half-life and can Effectively control blood pressure within a day, so it is more convenient to take. At the same time compared with other angiotensin II receptor antagonist drugs. It has obvious advantages such as small dose, quick onset, stronger and lasting antihypertensive effect, and low incidence of adverse reactions. Clinical studies have shown that: Olmesartan medoxomil can also be taken at the same time with other antihypertensive drugs to achieve a more ideal therapeutic effect. In addition, Olmesartan has good effects on arteriosclerosis, myocardial hypertrophy, heart failure, diabetes, and kidney disease.
